TELA Bio Highlights NHS Surgeon First In Europe To Implant Co’s OviTex LPR Reinforced Tissue Matrix
TELA Bio, Inc. (NASDAQ:TELA), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction,